SeekInClarity: Blood-Based Multi-Omics Test Offers Promising Advance in Monitoring Cancer Treatment Response
A new prospective study published in BMC Cancerdemonstrates that a novel blood-based multi-omics test, SeekInClarity, can accurately assess and predict therapeutic outcomes in lymphoma patients across different subtypes-potentially transforming how clinicians monitor treatment response. Study Highlights — Innovative Approach:The SeekInClarity test integrates genomic, epigenetic, and proteomic signals from blood samples to calculate a molecular tumor […]